HEALTHY VOLUNTEER

This early-stage study tests a new medicine called REGN20423 for the first time in humans. It will check the drug's safety, how the body handles it, and what dose might work best. The study includes 136 people: healthy volunteers and adults with atopic dermatitis (eczema). Resear…

This study looks at two treatments—low-level laser therapy and hyaluronic acid gel—to help children's gums heal after removing a badly decayed first permanent molar. About 36 children aged 6 to 10 will take part. The goal is to see which method reduces wound size and improves gum…

This study looks at how meals with different amounts of fat, carbs, and protein change fat levels in the blood. Researchers will study 100 adults with conditions like diabetes, metabolic syndrome, or kidney disease, plus healthy volunteers. Participants will eat two different bre…

This study tests two liquid forms of metformin (a common diabetes medicine) to see how well they are absorbed compared to regular tablets. It involves 24 healthy adults aged 18 to 55. The goal is to measure drug levels in the blood, not to treat any disease.

This study looks at how five common tuberculosis drugs move through the body and into breast milk in healthy breastfeeding women. Sixty women will each receive a single dose of one drug, and researchers will measure drug levels in their blood and milk. The goal is to gather safet…

This early-stage study tests a new drug called HSK56630 for the first time in humans. About 40 healthy adults will receive either a single dose of the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to see if it is safe enough for …

This study looks at how early life events might affect eating behaviors and weight gain in adults. Researchers will observe 110 healthy volunteers aged 18 to 60. Participants will have body measurements, wear activity and glucose monitors, answer questionnaires, and eat from a bu…

This early-stage study tests a new drug called REGN22044 in 64 healthy adults for the first time. Researchers will check for side effects, measure drug levels in the blood, and see if the body makes antibodies against it. The goal is to gather safety information, not to treat any…

This study is the first time ABBV-1451 is given to humans. It aims to check the drug's safety, how the body processes it, and whether it triggers an immune response. About 90 healthy adults, including Japanese and Han Chinese participants, will receive a single dose. This is an e…

This study tests whether two liquid forms of metformin work the same as the standard tablet in healthy adults. Twenty-four participants will receive both versions in random order, with blood samples taken to measure drug levels. The goal is to see if the liquid forms are equivale…

This study looks at how running very long distances (like 50+ miles) affects women's hearts and body inflammation. Researchers will track 120 female runners before and after a race, measuring heart function, blood markers, and hormone levels. The goal is to understand these chang…

This study looks at brain activity in teens aged 10-17 with ADHD, OCD, or no condition to understand how they control thoughts and actions. Participants will have up to 10 visits over a year, including computer tasks, EEG (brain wave recording), MRI (brain imaging), and optional …

This study tests whether tiny bubbles filled with hydrogen and oxygen can be safely given through a vein to adults. It is the first time this has been tried in humans, so the main goal is to check for side effects and find a safe dose. About 40 healthy adults or those with mild h…

This study looks at how two common drugs (itraconazole and ticagrelor) change the way the body handles a new drug called AL3818. It involves 16 healthy volunteers aged 18 to 45. The goal is to gather safety and processing data, not to treat any disease.

This early-stage study will test a new liquid version of the diabetes drug metformin in 24 healthy adults aged 18 to 55. Participants will receive both the liquid and standard tablet forms at different times to compare how the body absorbs each. The goal is to see if the liquid w…

This study collects data from 150 healthy children aged 6-11 to improve the QbMobile test, which measures attention, impulsivity, and activity. The goal is to make the test more accurate when comparing results from children with possible ADHD. Participants take a short computer-b…

This study aims to create a Turkish version of a questionnaire that measures how easy and comfortable virtual reality systems are to use. Researchers will ask 54 healthy volunteers aged 18-50 to test the questionnaire after using VR. The goal is to make sure the Turkish version i…

This study tests how the drug risankizumab behaves in the body when given as a shot under the skin versus through a vein. It involves 60 healthy adults and aims to measure drug levels and any side effects. The results will help guide future dosing for patients with conditions lik…

This study looks at how a new tablet (IN-M00002) moves through the body when taken alone or with other drugs (tegoprazan and naproxen), and how food affects it. It involves 74 healthy adults aged 19 to 55. The goal is to gather safety and drug-level information, not to treat any …